B. Riley Wealth Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-5,615
| Closed | -$230K | – | 1582 |
|
2023
Q2 | $230K | Sell |
5,615
-389
| -6% | -$16K | 0.01% | 1275 |
|
2023
Q1 | $215K | Sell |
6,004
-2,732
| -31% | -$97.6K | 0.01% | 1260 |
|
2022
Q4 | $330K | Buy |
8,736
+1,404
| +19% | +$53K | 0.01% | 996 |
|
2022
Q3 | $325K | Sell |
7,332
-1,070
| -13% | -$47.4K | 0.01% | 955 |
|
2022
Q2 | $312K | Sell |
8,402
-696
| -8% | -$25.8K | 0.01% | 857 |
|
2022
Q1 | $337K | Buy |
9,098
+2,377
| +35% | +$88K | 0.01% | 956 |
|
2021
Q4 | $205K | Sell |
6,721
-4,297
| -39% | -$131K | 0.01% | 1258 |
|
2021
Q3 | $379K | Sell |
11,018
-188
| -2% | -$6.47K | 0.01% | 922 |
|
2021
Q2 | $454K | Sell |
11,206
-1,792
| -14% | -$72.6K | 0.01% | 816 |
|
2021
Q1 | $616K | Sell |
12,998
-7,603
| -37% | -$360K | 0.02% | 638 |
|
2020
Q4 | $1.17M | Buy |
20,601
+949
| +5% | +$53.7K | 0.06% | 290 |
|
2020
Q3 | $963K | Buy |
19,652
+1,833
| +10% | +$89.8K | 0.05% | 316 |
|
2020
Q2 | $1.05M | Sell |
17,819
-399
| -2% | -$23.5K | 0.07% | 272 |
|
2020
Q1 | $861K | Buy |
18,218
+10,595
| +139% | +$501K | 0.07% | 263 |
|
2019
Q4 | $461K | Buy |
7,623
+1,543
| +25% | +$93.3K | 0.04% | 464 |
|
2019
Q3 | $365K | Buy |
6,080
+1,237
| +26% | +$74.3K | 0.04% | 519 |
|
2019
Q2 | $312K | Buy |
+4,843
| New | +$312K | 0.03% | 548 |
|
2016
Q1 | – | Sell |
-4,142
| Closed | -$258K | – | 582 |
|
2015
Q4 | $258K | Buy |
+4,142
| New | +$258K | 0.05% | 415 |
|
2015
Q3 | – | Sell |
-3,727
| Closed | -$216K | – | 584 |
|
2015
Q2 | $216K | Buy |
+3,727
| New | +$216K | 0.05% | 428 |
|
2015
Q1 | – | Sell |
-1,220
| Closed | -$75 | – | 1255 |
|
2014
Q4 | $75 | Buy |
+1,220
| New | +$75 | ﹤0.01% | 1870 |
|